The results showed that the top 5 in terms of signal strength were angioimmunoblastic T-cell lymphoma refracto (n = 3, EBGM = 525.73), FLT3 gene mutation (n = 5, EBGM = 438.11), myelodysplastic syndrome transformation (n = 120, EBGM = 275.66), juvenile chronic myelomonocytic leukaemia (n = 9, EBGM = 234.90), transformation to acute myeloid leukaemia (n = 91, EBGM = 213.03). The gene discussed is FLT3; the disease is chronic myelomonocytic leukemia.